n-hydroxysuccinimide has been researched along with Cicatrization in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alarcon, EI; Cron, G; Goel, K; Hosoyama, K; Liang, W; McLaughlin, S; McNeill, B; Podrebarac, J; Rayner, KJ; Ruel, M; Sedlakova, V; Seymour, R; Smyth, D; Suuronen, EJ | 1 |
1 other study(ies) available for n-hydroxysuccinimide and Cicatrization
Article | Year |
---|---|
Injectable human recombinant collagen matrices limit adverse remodeling and improve cardiac function after myocardial infarction.
Topics: Animals; Capillaries; Carbodiimides; Cell Proliferation; Cell Survival; Cicatrix; Collagen Type I; Collagen Type III; Coronary Vessels; Cross-Linking Reagents; Dimethylamines; Heart; Humans; Macrophages; Mice; Monocytes; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Recombinant Proteins; Succinimides; Ventricular Function; Ventricular Remodeling | 2019 |